Perioperative Propranolol: A Useful Adjunct for Glaucoma Surgery in Sturge-Weber Syndrome

Sushmita Kaushik1, Pankaj Kataria1, Gunjan Joshi1

  • 1Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Perioperative oral propranolol significantly reduced sight-threatening choroidal effusions in Sturge-Weber syndrome (SWS) patients undergoing glaucoma surgery. This treatment appears safe and effective for managing ocular complications in SWS.

Area of Science:

  • Ophthalmology
  • Vascular Disorders
  • Pharmacology

Background:

  • Sturge-Weber syndrome (SWS) presents ocular issues like choroidal hemangioma and glaucoma.
  • Glaucoma surgery in SWS patients risks sight-threatening choroidal effusions.
  • The efficacy of propranolol for choroidal hemangioma is understudied.

Purpose of the Study:

  • To investigate the role of perioperative oral propranolol in preventing choroidal effusions during glaucoma surgery in SWS patients.
  • To assess the safety and efficacy of propranolol in this context.

Main Methods:

  • A prospective, nonrandomized case series of 14 eyes from 12 SWS patients undergoing glaucoma surgery.
  • Patients received oral propranolol (2 mg/kg/day) preoperatively and postoperatively.
  • Outcomes were compared to historical controls (15 eyes from 14 patients) who did not receive propranolol.

Main Results:

  • No patients in the propranolol group developed sight-threatening choroidal effusions.
  • Two patients with bilateral SWS had peripheral effusions that resolved with medical management.
  • The control group experienced a higher incidence of choroidal effusions, some requiring surgical intervention.
  • No adverse effects of propranolol were observed.

Conclusions:

  • Perioperative oral propranolol appears effective in minimizing sight-threatening choroidal effusions after glaucoma surgery in SWS patients.
  • Propranolol demonstrates a favorable safety profile in this patient population.
  • This approach may improve surgical outcomes for SWS patients with glaucoma.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
869
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
352
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
178